Stockreport

OnKure Therapeutics to Present at Upcoming Leerink and Stifel Investor Conferences

OnKure Therapeutics, Inc. - Class A  (OKUR) 
PDF BOULDER, Colo., March 04, 2025 (GLOBE NEWSWIRE) -- OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on the development of n [Read more]